GBMSummit

Dedicated to accelerating the clinical development of therapies to treat glioblastoma. For more details, visit

[GBMSummit @GbmSummit]

Join @NBTStweets, @blackstone, @Merck, @servier, @RACapitalMgmt, @RBC, @whitelioncapital to bridge the gap between scientific innovation and funding with the expert Investor Panel!
Access the full event guide here: https://t.co/eFidFJUwXv

[GBMSummit @GbmSummit]

Register TODAY — the 6th Annual @GbmSummit allows you to collaborate with key decision-makers in the #glioblastomadrug development space.

Unlock curated insights to breakthrough GBM barriers here: https://t.co/8eIdUbw1ae

Register by FRIDAY and save $900: ttps://ter.li/1tfm17

[GBMSummit @GbmSummit]

📣Don't miss out! The final chance to save ends this Friday, February 23

Register now to join 100+ of the brightest minds in pharma, biotech, and academia to celebrate our victories, face our challenges, and chart a path forward.

Secure your place here: https://t.co/m2rlF31vgY

[GBMSummit @GbmSummit]

Don't miss this opportunity to tackle the common issue of risk-aversity in GBM Funding!

Our expert investor panel is gearing up to provide valuable insights to overcome this frustrating hurdle,
with more experts to be announced!

Full details here: https://t.co/BCdbiHpeSy

[GBMSummit @GbmSummit]

Transforming #Glioblastoma: Pharma, biotech, neurosurgeons, academics, and investors unite for this industry-leading event with top companies like @MimiVax_Inc, @Novartis, @bmsnews and more!

Save up to $600 by registering your place now using this link: https://t.co/WIXeYLJYp3

[National Brain Tumor Society @NBTStweets]

Register TODAY — the 5th Annual @GbmSummit allows you to collaborate with key decision-makers in the #glioblastoma drug development space.

As chair of the event, our CSO @NBTSCSO will speak along with more than 30 leading industry experts: https://t.co/9B00DfHMdS #BTSM

[GBMSummit @GbmSummit]

Save up to $1,100 by booking your pass for the 5th Glioblastoma Drug Development Summit by midnight TOMORROW, Nov 17th!
In an exciting time for GBM, there has never been a better moment to unite with your community & break through barriers to saving lives.
https://t.co/tC5uEGd8Dw

[GBMSummit @GbmSummit]

Featuring our 30+ pioneering speakers from @DayOneBio @NBTStweets @Erasca @Novartis @bmsnews @MimiVax_Inc @harvardmed @DanaFarber @GCAResearch and many more!

[GBMSummit @GbmSummit]

After working closely with leading minds in the brain tumor space, we are excited to share the official programme for the 5th Glioblastoma Drug Development Summit! (Boston, March 26-28, 2024)

Check out our packed 3-day agenda here!
https://t.co/7SK4aANiDp

[Nature Cancer @NatureCancer]

Don’t miss our @NatureCancer OCTOBER ISSUE 🎃

This one features interesting articles on #glioblastoma therapy, #immunotherapy for AML, #immunometabolism, a Phase I #ClinicalTrial in ovarian cancer and more.

Check it out here👇
https://t.co/kQB1DePc4u

[Journal of Neuro-Oncology @JNeurooncol]

In this retrospective study from @McGillMed, Mohammad et al. identified an association between metformin use and increased overall survival in MGMT promotor methylation positive #glioblastoma
Read more: https://t.co/JuHVqrVgxl
#JNO #MedEd #BTSM #neurooncology #braintumor

[Day One Biopharmaceuticals @DayOneBio]

We are pleased to share that the FDA accepted our New Drug Application (NDA) and granted priority review for tovorafenib in relapsed or progressive pediatric low-grade glioma (pLGG). Learn more: https://t.co/TrC2Y8fMMH

[UT MD Anderson @UTMDAnderson]

In the search for better glioblastoma treatment, brain cancer researchers face many challenges. “But if we don’t push it, those patients are not going to get better,” says our Dr. Hussein Tawbi. https://t.co/8gwVADplRZ @Bloomberg @HTawbi_MD #glioblastoma #EndCancer

[Renishaw Medical @RenishawMedical]

We're delighted to be attending the 4th @GbmSummit Boston, US. We're looking forward to discussions with key decision-makers in the #glioblastoma drug development space about tackling specific #drugdelivery challenges.
https://t.co/qp0JEYj8Vn
#GBMSummit #ClinicalTrails #BBB #GBM

[Candel Therapeutics @CandelTx]

Don’t miss Candel President and CEO, Dr. @paulpetertak, at the 4th Annual @GbmSummit, where he will discuss how Candel is developing its viral immunotherapies to help improve survival rates & quality of life for people w/ #cancer. Learn more here: https://t.co/e3B8HZtF7V

[Global Coalition for Adaptive Research @GCAResearch]

.@meredith_buxton presenting at @GBMSummit during the #GBMAGILE panel discussion with @J_deGrootMD, @NBTStweets CEO @dfarons, GCAR CBO Robert Murray, and @KaziaTx CEO James Garner

[Michael Ciesielski @MJCiesielski]

Looking forward to attending @GBMSummit next week March 14-16. Please reach out to discuss partnership & investment opportunities for #SurVaxM immunotherapy. Phase 2a mOS of 25.9 mos. in nGBM (https://t.co/5WChP9h7sm) https://t.co/QOw6EDOETq

[Sara G.M. Piccirillo, PhD @SaraGMP]

Thanks @UNMCCC! I am grateful to @Novocure for the opportunity to speak at the @GbmSummit. Looking forward to sharing the work of our Brain Tumor Translational Lab🧠 @UNMHSC @UNMCCC, interacting with participants and discussing the new frontiers in treating #glioblastoma #gbm

[UNM Comprehensive Cancer Center @UNMCCC]

Congratulations to Dr. Sara Piccirillo, who was invited to speak at the 4th Annual Glioblastoma Drug Development Conference this month in Boston. To learn more about Dr. Piccirillo's work, click here: https://t.co/DOj5D9u61S

[Global Coalition for Adaptive Research @GCAResearch]

The 4th Annual @GBMSummit is 2 weeks away!🧠 Don't miss: #GBMAGILE – An evergreen registrational model for evaluating new treatments for #GBM on March 15 featuring GCAR CEO @meredith_buxton, GCAR CBO Robert Murray, @KaziaTx CEO James Garner, and @NBTStweets CEO @dfarons